MAIA (STOCKS)
MAIA Biotechnology, Inc.
$2.019700
+0.249700 (+14.11%)
Prev close: $1.770000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Vlad Vitoc
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $72.58M
- Employees
- 13
- P/E (TTM)
- -2.65
- P/B (TTM)
- 1,462.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.27 | $-0.19 | -0.0762 | -39.32% |
|
Jun 2025 (Q2)
|
$-0.18 | $-0.24 | +0.0648 | +26.47% |
|
Mar 2025 (Q1)
|
$-0.16 | $-0.18 | +0.0236 | +12.85% |
|
Dec 2024 (Q4)
|
$-0.12 | $-0.36 | +0.2370 | +66.39% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $24.96M |
| Operating Income/Loss | -$24.96M |
| Income/Loss From Continuing Operations After Tax | -$22.38M |
| Income/Loss From Continuing Operations Before Tax | -$22.38M |
| Net Income/Loss | -$22.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.74 |
| Diluted Earnings Per Share | -$0.74 |
| Basic Average Shares | 31,369,892 |
| Diluted Average Shares | 31,369,892 |
| Assets | $11.78M |
| Current Assets | $11.75M |
| Noncurrent Assets | $27.09K |
| Liabilities | $11.74M |
| Current Liabilities | $9.99M |
| Accounts Payable | $3.18M |
| Other Current Liabilities | $6.82M |
| Noncurrent Liabilities | $1.75M |
| Equity | $41.67K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $41.67K |
| Liabilities And Equity | $11.78M |
| Net Cash Flow From Operating Activities | -$15.73M |
| Net Cash Flow From Operating Activities, Continuing | -$15.73M |
| Net Cash Flow From Investing Activities | -$2.22M |
| Net Cash Flow From Investing Activities, Continuing | -$2.22M |
| Net Cash Flow From Financing Activities | $17.95M |
| Net Cash Flow From Financing Activities, Continuing | $17.95M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$22.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.36M |
| Other Comprehensive Income/Loss | $896.18K |